Wenger Pascale, Frey Urs, Nadal David
Swiss Clinical Trial Organisation (SCTO), Basel, Switzerland.
University Children's Hospital Basel, Switzerland.
Swiss Med Wkly. 2014 Sep 25;144:w14006. doi: 10.4414/smw.2014.14006. eCollection 2014.
Conducting clinical studies in the paediatric population is complex and difficult. Paediatricians deal with a vulnerable population, which primarily needs protection and where patient numbers are always low. In addition, the pharmaceutical industry often demonstrates lack of interest due to the small and non-rewarding market. Public awareness for the need of paediatric research is likewise limited. This results in lack of funding for academic studies. In Switzerland, there is a new initiative that strives to overcome the given barriers and hurdles. SwissPedNet is still in a start-up phase, but it is now ready for all collaborations of interest and keen to work together with all stakeholders on the medical progress and improvement of paediatric clinical research with the overall goal of implementing evidence-based medicine for our children (www.swisspednet.ch).
在儿科人群中开展临床研究复杂且困难。儿科医生面对的是弱势群体，他们主要需要保护，而且患者数量一直很少。此外，由于市场规模小且无利可图，制药行业常常表现出缺乏兴趣。公众对儿科研究需求的认识同样有限。这导致学术研究资金短缺。在瑞士，有一项新举措致力于克服这些障碍。瑞士儿科研究网络仍处于起步阶段，但现在已准备好开展所有感兴趣的合作，并渴望与所有利益相关者共同努力推动儿科临床研究的医学进步和改善，总体目标是为我们的儿童实施循证医学（www.swisspednet.ch）。
